PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
EoCP-1 1 Target Disease Asthma 109,610 1 0.00 -0.71 1.00 0.61
CD4 112,219 Target Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.60
CD4 112,219 Target Disease Infection Upper Respiratory Tract 1 1 0.00 -0.71 1.00 0.61
Adp/Atp Translocase 3 2 Target Disease Breast Cancer 173,695 1 0.00 -0.71 0.50 0.60
CSF2/GM-CSF 2 Target Disease Infection 766,637 1 0.00 -0.71 0.50 0.57
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
CCL2 3,560 Target Target CCL3 1,427 533 0.24 -0.73 0.37 0.85
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
CCL5 2,002 Target Target CCL2 3,560 673 0.25 -0.73 0.34 0.87
Retinoic Acid Receptor Alpha 1,068 Target Disease Leukemia 162,805 490 0.04 -0.73 0.46 0.66
CCL7 274 Target Target CCL8 197 60 0.26 -0.74 0.30 0.90
Vascular Cell Adhesion Protein 1 31 Target Disease Inflammation 252,734 14 0.01 -0.74 0.45 0.60
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CINC-2- alpha 9 Target Disease Inflammation 252,734 4 0.00 -0.75 0.44 0.59
BAFF 1,240 Target Target BLyS 457 164 0.22 -0.75 0.36 0.86
CCL4 5,638 Target Target CCL3 1,427 535 0.19 -0.75 0.37 0.83